Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 803 of 1,261

  1. US 8785409

    Compounds having anti-adhesive effects on cancer cells

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  2. US 8785407

    Antisense antiviral agent and method for treating ssRNA viral infection

    Sarepta Therapeutics, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  3. US 8785191

    Concentration of stem cells obtained during orthopaedic surgeries

    UNIVERSITY OF CONNECTICUT · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  4. US 8785393

    Ophthalmic pharmaceutical compositions of DP2 receptor antagonists

    Panmira Pharmaceuticals, LLC · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  5. US 8785414

    Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  6. US 8785444

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  7. US 8785377

    Tetrazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  8. US 8785429

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  9. US 8785442

    Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof

    Curegenix, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  10. US 8785449

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  11. US 8785460

    Tricyclic compounds and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  12. US 8785486

    Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  13. US 8785483

    Methods for treating COPD

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  14. AU 2012362562

    Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione

    CELGENE CORP [CH] · Granted Jul 17, 2014 · Expires Jul 12, 2034

    granted

  15. US 8778398

    Immediate release formulations and dosage forms of gamma-hydroxybutyrate

    Jazz Pharmaceuticals, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  16. US 8778876

    Small-molecule inhibitors of Dengue and West Nile virus proteases

    The Board of Regents of the University of Texas System · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  17. US 8778938

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  18. US 8778871

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  19. US 8778343

    Antibodies that bind tau oligomers

    The Board of Regents of the University of Texas System · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  20. US 8778983

    Polycyclic compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  21. US 8778671

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  22. US 8778934

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  23. US 8778870

    Modified factor IX polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  24. US 8778844

    Structured peptide processing

    BICYCLE THERAPEUTICS LIMITED · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.